Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
1.60 0.05(3.23%) Jul 25, 4:00PM EDT
Prev Close:1.55
Open:1.53
Bid:0.80 x 200
Ask:3.12 x 500
1y Target Est:5.00
Beta:1.4
Next Earnings Date:N/A
Day's Range:1.51 - 1.61
52wk Range:1.25 - 3.70
Volume:75,840
Avg Vol (3m):208,198
Market Cap:44.26M
P/E (ttm):N/A
EPS (ttm):-0.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OPXA

Comparison

Symbol% ChgMkt Cap
OPXAUp 3.23%44.26M
SNY134.64B
TEVA46.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Jun-14) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback